Study on intervention of DCP on MAPK signaling pathway to inhibit inflammatory response and alleviate progression of liver fibrosis in rats
- Author:
Jie XU
1
;
Ming-Li ZHONG
1
;
Yue-Feng WANG
1
;
Bo LL
1
;
Jia-Jia HAN
1
;
Ya GAO
1
;
Ke-Feng ZHANG
1
Author Information
- Publication Type:Journal Article
- Keywords: 2,4- dimethylnitrosamine; dicliptera chinensis polysaccharides; hepatic fibrosis; inflammatory factors; MAPK pathway
- From: Chinese Pharmacological Bulletin 2022;38(4):531-537
- CountryChina
- Language:Chinese
- Abstract: Aim To investigate whether DCP has pro- teetive effeet on 2 ,4-dimethylnitrosamine ( DMN) -induced liver fibrosis rat model and its effect on MAPK signaling pathway.Methods Hats were intraperitoneal ly injected with DMN to establish HF model,and then were randomly divided into five groups, namely model group, colchicine group, DCP low-dose, medium-dose and high-dose groups,and control group.The rats were given DMN continuously for six weeks.Serum was col-lected afterwards to detect biochemical indexes of liver function.HE and Masson staining and immunohisto- chemical experiments were performed on liver tissues.RT-PCR was applied to detect the expression of inflammatory factors.Western blot was used to detect the ex pression of proteins related to MAPK pathway,the preventive effect of DCP on HF was observed, and its in-tervention effect on MAPK pathway was explored.Results The liver function of rats in model group was severely impaired, with obvious hepatocyte damage, inflammatory cell infiltration and increased interstitial fibrosis , suggesting that the preparation of HF model was successful.Conclusions DCP can interfere with MAPK signaling pathway to inhibit the inflammatory response and alleviate the progression of HF in rats.
